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Lymnaea stagnalis UDP-GlcNAc:GlcNAcb-R b134-N-
acetylglucosaminyltransferase (b4-GlcNAcT) is an en-
zyme with structural similarity to mammalian UDP-Gal:
GlcNAcb-R b134-galactosyltransferase (b4-GalT). Here,
we report that also the exon organization of the genes
encoding these enzymes is very similar. The b4-GlcNAcT
gene (12.5 kilobase pairs, spanning 10 exons) contains
four exons, encompassing sequences that are absent in
the b4-GalT gene. Two of these exons (exons 7 and 8)
show a high sequence similarity to part of the preceding
exon (exon 6), suggesting that they have originated by
exon duplication. The exon in the b4-GalT gene, corre-
sponding to b4-GlcNAcT exon 6, encodes a region that
has been proposed to be involved in the binding of UDP-
Gal. The question therefore arose, whether the repeat-
ing sequences encoded by exon 7 and 8 of the b4-Glc-
NAcT gene would determine the specificity of the
enzyme for UDP-GlcNAc, or for the less preferred UDP-
GalNAc. It was found that deletion of only the sequence
encoded by exon 8 resulted in a completely inactive
enzyme. By contrast, deletion of the amino acid residues
encoded by exons 7 and 8 resulted in an enzyme with an
elevated kinetic efficiency for both UDP-sugar donors,
as well as for its acceptor substrates. These results sug-
gest that at least part of the donor and acceptor binding
domains of the b4-GlcNAcT are structurally linked and
that the region encompassing the insertion contributes
to acceptor recognition as well as to UDP-sugar binding
and specificity.
Glycosyltransferases form a large family of functionally re-
lated, membrane-bound enzymes that are involved in the bio-
synthesis of the carbohydrate moieties of glycoproteins and
glycolipids (1, 2). Recently we have identified a novel glycosyl-
transferase by the isolation of a UDP-GlcNAc:GlcNAcb-R
b134-N-acetylglucosaminyltransferase (b4-GlcNAcT)1 cDNA
from the prostate gland of the snail Lymnaea stagnalis (3). In
vitro, the recombinant b4-GlcNAcT catalyzes the transfer of
GlcNAc from UDP-GlcNAc in b134 linkage to various b-N-
acetylglucosaminides (3, 4). The b4-GlcNAcT cDNA appeared
to show a significant sequence similarity to the mammalian
UDP-Gal:GlcNAcb-R b134-galactosyltransferase (b4-GalT)
cDNAs, with an overall resemblance between the predicted
amino acid sequences of about 30% (3, 5–7). Based on the
genetic and enzymatic relationship of the b4-GlcNAcT and the
b4-GalTs, we have suggested that these enzymes constitute a
separate glycosyltransferase gene family, the members of
which are capable of catalyzing the transfer of a specific sugar
from their respective UDP-sugar donors in a b134 linkage
toward a terminal b-linked GlcNAc residue in the acceptor (3,
8). Based on enzymatic properties, we have proposed that also
UDP-GalNAc:GlcNAcb-R b134-N-acetylgalactosaminyltrans-
ferase (b4-GalNAcT), detected in several non-vertebrate spe-
cies (9–13), belongs to this family (14). The primary structure
of this enzyme, however, is still unknown.
The reaction catalyzed by glycosyltransferases typically in-
volves two substrates and often a divalent cation cofactor. This
suggests that the enzymes consist of several functional do-
mains involved in substrate and cofactor binding, respectively.
Comparison of the conserved and variable regions of geneti-
cally related glycosyltransferases with different properties
would open possibilities to address structure-function relation-
ships. As snails and mammals are evolutionary distant species,
comparison of the genomic organization of the genes that en-
code these enzymes might give insight in their way of diver-
gence, that resulted in genes encoding enzymes with a different
UDP-sugar specificity. The genomic organization of the murine
and human b4-GalT genes have been described previously (15,
16). Here we report the organization of the L. stagnalis gene
that codes for the b4-GlcNAcT. The intron-exon distribution
was determined and compared with that of the b4-GalT gene.
Mutant b4-GlcNAcT cDNAs were constructed by deletion of
sequences that do not have a counterpart in the b4-GalT gene,
and expressed in COS cells. Comparison of the kinetic param-
eters of the resulting mutant and parental enzymes showed
that the insertion in the b4-GlcNAcT and its surrounding re-
gions contribute to acceptor recognition as well as to UDP-
sugar binding and specificity.
EXPERIMENTAL PROCEDURES
Materials, Bacterial Strains, and Cells—Acceptor substrates were
obtained from Sigma (compounds 1, 2, and 3) and from Toronto Re-
search Chemicals (compounds 5 and 6). Compound 4 was a gift of Dr. O.
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
¶ To whom reprint requests should be addressed: Dept. of Medical
Chemistry, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT
Amsterdam, The Netherlands. Tel.: 31-20-4448157; Fax: 31-20-
4448144; E-mail: im.van_die.medchem@med.vu.nl.
1 The abbreviations used are: b4-GlcNAcT, UDP-GlcNAc:GlcNAcb-R
b134-N-acetylglucosaminyltransferase; b4-GalNAcT, UDP-GalNAc:
GlcNAcb-R b134-N-acetylgalactosaminyltransferase; b4-GalT, UDP-
Gal:GlcNAcb-R b134-galactosyltransferase; kb, kilobase pair(s); PCR,
polymerase chain reaction; HPAEC, high pH anion-exchange chroma-
tography; PAD, pulsed amperometric detection; pNP, para-nitrophenyl;
WFA, W. floribunda lectin.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 272, No. 30, Issue of July 25, pp. 18580–18585, 1997
© 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org18580
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
Hindsgaul, University of Alberta, Alberta, Canada. UDP-[3H]GlcNAc,
UDP-[3H]GalNAc and UDP-[3H]Gal were purchased from NEN Life
Science Products, and were diluted with unlabeled UDP-sugars (Sigma)
to the desired specific radioactivity.
Recombinant plasmids were propagated in the Escherichia coli K12
strain XL1-Blue (Stratagene). COS-7M6 cells (ATCC 1651) were grown
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
calf serum, 2 mM L-glutamine, and 1:50 penicillin/streptomycin solution
(all from Life Technologies, Inc.). Synthetic oligonucleotides were ob-
tained from Isogen Bioscience BV (Maarssen, the Netherlands).
DNA Techniques—The genomic clone l5 has been isolated previously
(3) from a genomic lEMBL3A library of L. stagnalis (17). Isolation of
plasmid DNA was carried out by a modification of the minilysate
method, as described in Ref. 18. Plasmids used for transfection of COS
cells were isolated by the Qiagen plasmid protocol, using a QIAGEN-tip
100 minicolumn. Restriction enzymes and other DNA-modifying en-
zymes were used according to the manufacturer. Dideoxynucleotide
chain-terminating sequencing reactions (19) were performed on double-
stranded plasmid DNA, with the T7 DNA sequencing kit (Pharmacia
Biotech Inc.), [a-35S]dATP (Amersham), using M13 universal primer,
the KS and SK primers, and several sequence-specific synthetic oligo-
nucleotide primers. Southern blotting was performed as described pre-
viously (3). PCR with sequence-specific primers was performed using
Ultma-polymerase (Perkin-Elmer) by 25 cycles (1 min at 95 °C, 1 min at
63 °C, 1 min at 72 °C). For cloning purposes, amplified fragments were
subsequently purified according to the QIAquick PCR purification pro-
tocol (Qiagen Inc.)
Construction of pPROTA Hybrid Plasmids—The plasmid pMC135,
containing a fusion between part of the protein A sequence and b4-
GlcNAcT cDNA, was constructed as follows. A BamHI-EcoRI adapter
was ligated in the BamHI site of pVTBac-P11.4, carrying 59-truncated
b4-GlcNAcT cDNA (3). The resulting 1.4-kb EcoRI fragment from this
construct was ligated into an EcoRI-digested pPROTA vector (20). Plas-
mids carrying mutant b4-GlcNAcT genes were derived from pMC135 by
exchange of the 0.52-kb XhoI-BglII fragment for a PCR fragment car-
rying the desired deletion. For PCR of the deletion fragments, a sense
primer (bases 439–456 of the b4-GlcNAcT cDNA; Ref. 3) and the
antisense primer ID8 (ATAGATCTTAAATCTGTCCGGGTTCACAT-
TCCAG) or ID16 (ATAGATCTTAAATCTGTTCGGGTGCACGTTC) was
used. The antisense primer ID8, used for construction of pMC142,
consists of a part complementary to the 39 end of exon 6, and a part (11
base pairs), complementary to the 59 end of exon 9 (BglII restriction site
underlined). The antisense primer ID16, used for construction of
pMC166, consists of a part complementary to the 39 end of exon 7, and
the same 59 part of exon 9 as ID8. PCR fragments obtained with these
primers were digested with XhoI and BglII, and ligated into XhoI-BglII-
digested pMC135. After transformation and plasmid isolation of several
transformants, the desired plasmids (pMC142 encoding protA-b4-
GlcNAcTD7–8 and pMC166 encoding protA-b4-GlcNAcTD8) were se-
lected by size determination of the internal SalI fragment followed by
determination of the nucleotide sequence of the complete XhoI-BglII
fragment with sequence-specific primers.
Expression in COS-7M6 Cells—Recombinant pPROTA chimeric con-
structs were transiently transfected to COS cells (3 3 105 cells/10-cm
dish), using the calcium phosphate precipitation technique as described
previously (21); after 24 h, the medium was replaced by fresh medium;
medium was harvested at 48, 72, and 96 h after transfection and each
time replaced by fresh medium. The harvested media were pooled,
stored at 220 °C in portions, and used as enzyme source for glycosyl-
transferase assays and Western blotting. Membrane bound recombi-
nant b4-GlcNAcT was produced with a pMT2-based construct as de-
scribed previously (3).
Western Blot Analysis—The Western blot analysis performed was
aimed on detection of the protein A part of the fusion proteins. The
proteins of 1 ml of pooled medium collected after transfection, were
separated by SDS-polyacrylamide gel electrophoresis on 10% gels using
the Mini-PROTEAN II system (Bio-Rad). Western blotting was per-
formed essentially as described previously (21). As first antibody, an
arbitrary mouse IgG monoclonal antibody (ED3, Ref. 22) was used,
which reacts with the protein A part of the hybrid proteins. The second
antibody used was a goat anti-mouse peroxidase conjugate (Tago, Inc.
Immunodiagnostic Reagents).
Glycosyltransferase Assays—Standard glycosyltransferase assays
were performed in a 50-ml reaction mixture containing either 25 nmol of
UDP-[3H]GalNAc (2 Ci/mol), UDP-[3H]GlcNAc (1 Ci/mol), or UDP-
[3H]Gal (1 Ci/mol), 5 mmol of sodium cacodylate buffer, pH 7.2, 1 mmol
of MnCl2, 0.2 mmol of ATP, and 50 nmol of p-nitrophenyl-N-acetyl-1-
thio-b-D-glucosaminide (GlcNAc-S-pNP). As enzyme source, 10 ml of
COS cell medium, which had been concentrated 10 times with Cen-
triprep-10 concentrators (Amicon), was used. The product was isolated
using Sep-Pak C-18 cartridges (Waters) (23). For acceptor specificity
studies, acceptor substrate concentrations were kept at 1 mM, in terms
of terminal GlcNAc residues. Control assays lacking the acceptor sub-
strate were carried out to correct for incorporation into endogenous
acceptors. Enzyme activity was expressed as pmol/min21/ml21 of the
original medium. As enzyme source for the experiments studying the
UDP-Gal specificity, the enzyme was isolated from the medium by
binding to IgG-agarose (Sigma). 10 ml of medium was incubated with 10
ml of IgG-agarose beads for 16 h at 4 °C, carefully shaking; the beads
were subsequently collected by centrifugation and resuspended in 500
ml of 0.1 M sodium cacodylate buffer, pH 7, containing 1 mg/ml bovine
serum albumin; 10 ml of this suspension was used in a standard assay.
Kinetic parameters (Km and V) were estimated from Lineweaver-
Burk plots by varying the sugar-donor concentrations from 0.05 to 0.5
mM for UDP-GlcNAc and from 0.25 to 5 mM for UDP-GalNAc while
keeping the GlcNAc-S-pNP concentration at 1 mM, or by varying the
acceptor substrate concentration from 0.025 to 1 mM while keeping the
UDP-GlcNAc concentration at 0.5 mM. The inhibitory effect of UDP was
studied at fixed concentrations of UDP-GlcNAc (0.5 mM) and GlcNAc-
O-pNP (1 mM), whereas the UDP concentration was varied from 0.1 to
5 mM.
Product Characterization—Product, obtained with the enzyme
protA-b4-GlcNAcTD7–8, GlcNAc-S-pNP, and UDP-[3H]-GalNAc, was
analyzed by lectin affinity chromatography with Wisteria floribunda
lectin (WFA), immobilized on azlactone/bisacrylamide polymeric beads
(3 M Emphaze™, Pierce) (24). The product was also analyzed by HPAEC-
PAD (3). As a control, both WFA lectin chromatography and HPAEC-PAD
analysis were performed with reference GalNAcb134GlcNAc-S-pNP
produced with L. stagnalis albumen gland b4-GalNAcT (9).
RESULTS
Isolation and Characterization of the L. stagnalis b4-Glc-
NAcT Gene—A genomic clone, denoted l5, was isolated previ-
ously from a lEMBL3A library of L. stagnalis, and was shown
to contain two short DNA sequences identical to b4-GlcNAcT
cDNA sequences (3). A rough genomic map of l5 was con-
structed by PCR and Southern blot hybridization using specific
b4-GlcNAcT cDNA fragments as probes (Fig. 1). l5 was found
to encompass the complete coding sequence of the b4-GlcNAcT
gene, spanning 12.5 kb of DNA, that was divided into 10 exons
(Fig. 1, Table I). As probably part of the 59-noncoding sequence
is lacking from the cDNA (3), we cannot exclude the presence in
the gene of one or more exons upstream of the denoted exon 1.
Exon 10 was found to encompass the complete 39-noncoding
region. All exon sequences in the genomic clone were identical
to those of the cDNA (3). Donor and acceptor splice junction
sequences (Table II) are in agreement with consensus se-
quences reported (25).
Comparison of the L. stagnalis b4-GlcNAcT Gene with the
Murine and Human b4-GalT Genes—The cDNA encoding b4-
GlcNAcT shows sequence identity with the mammalian b4-
GalT cDNAs identified (3, 5–7). A comparison of the protein-
coding exons of the L. stagnalis b4-GlcNAcT gene with those of
the murine and human b4-GalT genes (15, 16) is shown in Fig.
2. The b4-GalT gene was found to be divided into six exons,
whereas the b4-GlcNAcT gene appeared to contain 10 exons.
Exons 3, 4, 5, 6, and 9 of the b4-GlcNAcT gene were found to
show similarity to exons 2–6 of the b4-GalT gene, correspond-
ing to the catalytic domain of the enzyme (Fig. 2). This simi-
larity was not only confined to a high degree of sequence
FIG. 1. Schematic representation of the L. stagnalis b4-Glc-
NAcT gene. Exons 1–10 are represented by vertical bars. B, S, and X
indicate BamHI, SalI, and XhoI restriction sites, respectively.
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identity; intron/exon boundaries were also found at identical
positions within the gene.
The coding sequence of the b4-GlcNAcT gene is larger than
that of the b4-GalT gene. These additional sequences appeared
to be mainly encoded by three exons (exons 7, 8, and 10), that
were not present in the b4-GalT gene. Exons 7 and 8 were
found to encode a partial repeat of the sequence of exon 6 (Table
III). The sequence analysis of the intron/exon borders (Table II)
shows that exons 6, 7, and 8 are symmetrical exons. Addition-
ally, it was observed that the acceptor splice junction sites of
introns 6 and 7 as well as the donor splice junction sites of
intron 6, 7, and 8 and the adjacent exon sequences are identi-
cal. These data strongly suggest that exons 7 and 8 of the
b4-GlcNAcT gene arose by duplications (26), originating from
the downstream part of exon 6.
Construction and Expression of Deletion Derivatives of the
b4-GlcNAcT cDNA—Deletion derivatives of the b4-GlcNAcT
cDNA were constructed that lacked the sequences correspond-
ing to exon 8 or to exons 7 and 8 (Fig. 3). Plasmids were
constructed as gene fusions to part of protein A (20, 27). pMC
135 encodes a soluble, native b4-GlcNAcT (protA-b4-GlcNAcT).
pMC142 and pMC166 are plasmids encoding deletion deriva-
tives of pMC135, designated protA-b4-GlcNAcTD7–8 and
protA-b4-GlcNAcTD8, respectively. These three plasmids were
transiently expressed in COS cells. Essentially equal amounts
of hybrid protein per volume were secreted into the medium
(Fig. 4).
Enzyme Activity of the Chimeric Proteins—The enzyme ac-
tivities of the mutant hybrid proteins and the native protA-b4-
GlcNAcT were assayed using similar amounts of enzyme (Fig.
4). As the native membrane-bound b4-GlcNAcT shows a low
GalNAcT activity (about 7% of the b4-GlcNAcT activity), the
activity of the enzymes was measured with both UDP-GlcNAc
and UDP-GalNAc. ProtA-b4-GlcNAcTD7–8 showed reproduc-
ibly an almost 2 times higher GlcNAcT activity and a 4 times
higher GalNAcT activity than the parental protA-b4-GlcNAcT
(Table IV). In contrast to the other chimeric proteins, protA-
b4-GlcNAcTD8 appeared to be enzymatically inactive. To de-
termine if the enzymes would show GalT activity, the hybrid
proteins were purified using IgG-agarose beads. In this way,
the recombinant enzymes were completely disposed of COS
cell-derived b4-GalT. The bead-associated chimeras did not
show detectable GalT activity, whereas they showed GlcNAcT
and GalNAcT activities similar to those for the concentrated
media (results not shown).
Acceptor specificity studies, using UDP-GlcNAc as sugar
donor, showed no significant differences in acceptor preference
between the two active hybrid enzymes at an acceptor concen-
tration of 1 mM (Table V; Ref. 4). The acceptor specificity of the
mutant chimeric protein using UDP-GalNAc as a sugar-donor
appeared very similar to the preference of the enzyme when
using UDP-GlcNAc. By contrast, the prostate gland b4-GalN-
AcT is less specific for the linkage type of the terminal b-linked
GlcNAc, and its acceptor substrate requirement resembles that
of the albumen gland b4-GalNAcT (9).
Kinetic Properties of the Chimeric b4-GlcNAcTs—To explain
the differences in donor specificity in more detail, the Km and V
values for UDP-GlcNAc and UDP-GalNAc were determined for
both protA-b4-GlcNAcT and protA-b4-GlcNAcTD7–8. It ap-
pears that the increase in GlcNAcT activity of protA-b4-
GlcNAcTD7–8 is due to a 3-fold reduction in Km for UDP-
GlcNAc (Table VI), whereas the increased GalNAcT activity of
the mutant enzyme is mainly due to an enhanced maximum
velocity. These effects result in an elevated kinetic efficiency
for both types of transfer. The data suggest an involvement of
the region encoded by exons 7 and 8 in UDP-sugar donor
binding. However, it was found that both active chimera were
TABLE I
Exons of the L. stagnalis b4-GlcNAcT gene
Exon no. Exonlength
Corresponding
cDNA residues
Amino acids
encoded
bp
1 .52 23–52 1–17
2 399 53–451 18–150
3 233 452–684 151–228
4 191 685–875 229–292
5 123 876–998 293–333
6 102 999–1100 334–367
7 78 1101–1178 368–393
8 78 1179–1256 394–419
9 139 1257–1395 420–465
10 225 1396–1620 466–490
TABLE II
Introns of the L. stagnalis b4-GlcNAcT gene
Intron
no.
Intron
length
Splice junction sequence
Donor Acceptor
kb
1 1.0 AACAC:gtgagtagga tttctcccag:GCCAT
2 0.7 CTTAG:gtaaaaaaaa tttcgaacag:CTGGA
3 0.8 AACAG:gtgagaagga gtcttggcag:ACTAC
4 2.1 TACAA:gtgagcatcc tattttgcag:ACTTT
5 2.5 AACAG:gtaagacgtg tcgattgcag:GGCCG
6 0.5 CACAG:gtgagaccca atattaccag:CAAAG
7 0.9 AACAG:gtgagaccca atattaccag:CAAAT
8 1.3 GACAG:gtgagaccca gtatccccag:ATTTA
9 1.0 CGAAT:gtgagtgttt ctactttcag:AGCAT
FIG. 2. Schematic representation of organization of the pro-
tein-coding exons of the genes encoding L. stagnalis b4-Glc-
NAcT and human b4-GalT (16). The shaded boxes indicate exons that
show considerably amino acid identity between both genes. The open
boxes indicate exons that show no significant sequence similarity be-
tween the genes, or are present only in the b4-GlcNAcT gene. Homol-
ogous splice sites are connected by dotted lines.
TABLE III
Exons of the b4-GlcNAcT gene encoding repeated amino acid
sequences
Identical amino acids are indicated in boldface, and dash indicates a
gap in the amino acid sequence.
Exon Amino acid sequence encoded
6 AVHMKLPLLRKTLAHGLYDMVSH---VEAGWNVNPHS
7 KGAHSLYDMLNKALGVQAGWNVHPNS
8 KWPLRLFDSVNHAPAEGAGWNVNPDR
FIG. 3. Physical maps of the protein A-b4-GlcNAcT chimeric
plasmids. The open box represents pPROTA vector, and the thin line
inserted GlcNAcT cDNA. The positions of exons 6, 7, and 8 are indicated
in the cDNA. E, X, S, and B indicate the position of the restriction sites
for EcoRI, XhoI, SalI, and BglII, respectively, in the cDNA. pMC135
encodes protA-b4-GlcNAcT, pMC142 encodes protA-b4-GlcNAcTD7–8,
and pMC166 encodes protA-b4-GlcNAcD8.
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inhibited to almost the same extent by UDP (50% at 4–5 mM
UDP, results not shown).
The Km and V values of two acceptor substrates were esti-
mated (Table VII). While the V values of both enzymes ap-
peared to be of the same order for both compounds, the Km
values were decreased in the mutant enzyme. Deletion of the
two exons clearly elevates the kinetic efficiency with both ac-
ceptor substrates.
Characterization of the N-Acetylgalactosaminylated Product
Obtained with b4-GlcNAcTD7–8—The N-acetylgalactosaminy-
lated product formed by incubating protA-b4-GlcNAcTD7–8,
UDP-GalNAc, and GlcNAc-S-pNP was anticipated to be
GalNAcb134GlcNAc-S-pNP. To confirm this, the product was
compared with authentic GalNAcb134GlcNAc-S-pNP ob-
tained by the action of L. stagnalis albumen gland b4-GalNAcT
(9). Both product and reference were subjected to lectin affinity
chromatography with immobilized WFA, known to bind with
high affinity to glycans containing terminal GalNAc in a b134-
linkage (24, 28, 29). More than 90% of both compounds bound
to the immobilized WFA, and could be eluted with 10 mM
GalNAc. In addition, reference and product eluted on HPAEC
with the same retention time (data not shown). These results
indicate that b4-GlcNAcTD7–8 shows a b4-GalNAcT activity.
DISCUSSION
Based on the sequence identity of the mammalian b4-GalTs
and L. stagnalis b4-GlcNAcT, these enzymes have been pro-
posed to be members of one gene family (3). The observed
conservation of the exon-intron organization of the genes en-
coding these enzymes strengthens this view. All exons of the
b4-GalT gene show sequence identity to parts of the b4-Glc-
NAcT gene, which suggests that both genes originated from an
common ancestor, and diverged to genes encoding enzymes
with a different sugar donor specificity.
The most remarkable difference between the genes is found
in an insertion of two exons (exons 7 and 8) in the b4-GlcNAcT
gene. These exons were found to encode partial repeats of exon
6. The sequences of these exons and those of the bordering
introns strongly suggest that exons 7 and 8 were generated by
internal exon duplications, and originate from exon 6. This is
the first glycosyltransferase described in which exon duplica-
tion seems to have taken place during evolution. Generally,
exon duplication is thought to play an important role in the
evolution of genes, and many complex genes have been de-
scribed that have evolved by internal exon duplication and
subsequent modification of the primordial genes (30, 31).
FIG. 4. Western blot analysis of protA-fusion proteins. COS-
7M6 cells were transfected with the pPROTA vector and the pPROTA-
fusion plasmids, carrying the b4-GlcNAcT cDNA, or deletion deriva-
tives. Total cellular proteins, secreted into the medium, were separated
by SDS-polyacrylamide gel electrophoresis (10%). The proteins were
transferred to nitrocellulose. Antiserum reactions were directed against
the protein A part of the proteins. Lane 1, protA-b4-GlcNAcTD7–8; lane
2, protA-b4-GlcNAcTD8; lane 3, protA-b4-GlcNAcT; lane 4, pPROTA;
lane 5, molecular mass standards. Molecular masses on the right are
indicated in kDa.
TABLE IV
UDP-sugar donor promiscuity of protein A-b4-GlcNAcT
chimeras and deletion mutants derived thereof
Glycosyltransferase activities of the concentrated medium of trans-
fected COS cells were assayed as described under “Experimental Pro-
cedures” using UDP-GlcNAc and UDP-GalNAc as donors, respectively.
Enzyme
Glycosyltransferase activity with
UDP-GlcNAc UDP-GalNAc
pmol z min21 z ml21
protA-b4-GlcNAcT 210 15
protA-b4-GlcNAcTD8 ,1 ,1
protA-b4-GlcNAcTD7,8 361 67
TABLE V
Acceptor specificity of recombinant protA-b4-GlcNAcT and protA-b4-GlcNAcTD7,8
For the GlcNAcT assays 100% activity is 128 and 338 pmol z min21 z ml medium21, respectively. For the GalNAcT assays 100% activity is 110
pmol z min21 z ml medium21 for the mutant enzyme, and 5 nmol z min21 z ml21 for the prostate-derived enzyme.
Acceptor substrate
Activity with
UDP-GlcNAc UDP-GalNAc
protA-b4-GlcNAcT protA-b4-GlcNAcTD7,8
rec-b4-
GlcNAcTa
protA-b4-
GlcNAcTD7,8
Prostate gland
membranes
%
1 GlcNAcb-S-pNP 100 100 100 100 100
2 GlcNAcb-O-pNP 55 72 71 68 28
3 GlcNAcb134GlcNAcb-O-pNP 5 7 1 1 11
4 GlcNAcb132Mana1n6 ,1 ,1 ,1 1 48
Manb-O-RbGlcNAcb132Mana1m3
5 GlcNAcb133GalNAca-O-pNP 3 4 5 2 47
6 GlcNAcb1n6 96 86 104 136 67GalNAca-O-pNPGalb1m3
a Recombinant soluble b4-GlcNAcT from baculovirus infected insect cells (4).
b R 5 2(CH2)8-COOCH3.
TABLE VI
Kinetic parameters of protein A-b4-GlcNAcT chimeras and a deletion mutant derived thereof for two UDP-sugar donors
The recombinant enzymes were produced as protein A fusion proteins in COS cells.
Enzyme
UDP-GlcNAc UDP-GalNAc
Km V
Kinetic
efficiency Km V
Kinetic
efficiency
mM pmol z min21 z ml21 V z Km
21 mM pmol z min21 z ml21 V z Km
21
protA-b4-GlcNAcT 0.23 6 0.02 300 6 11 1304 2.0 6 0.6 92 6 13 46
protA-b4-GlcNAcTD7,8 0.08 6 0.01 380 6 12 4750 1.6 6 0.2 358 6 19 224
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To study the effect of the exon duplications on enzyme catal-
ysis, we deleted the sequence (52 amino acids) corresponding to
the two additional exons from the cDNA sequence. The cata-
lytic domain of the mutant protein thus obtained, might resem-
ble that of a putative ancestor of the L. stagnalis b4-GlcNAcT.
The deletion enhanced the kinetic efficiency of the enzyme for
both the transfer of GlcNAc and GalNAc, as well as for its
acceptor substrates. The acceptor substrate specificity, i.e. the
preference for a terminal b6-linked GlcNAc, was not affected.
So the mutant enzyme has an enhanced catalytic potential, but
also an increased sugar-donor promiscuity. Surprisingly, dele-
tion of only the sequence encoded by exon 8 resulted in a
completely inactive enzyme. An explanation could be that the
enzyme is not properly folded with only one additional repeat,
whereas the presence of two additional copies of the repeated
sequence allows a correct folding.
From the results obtained here, it is difficult to deduce the
selective advantage that was obtained by the exon duplications
for the biological function of the b4-GlcNAcT. As can be in-
ferred from the sequence, changes have occurred in the repeats
after the exon duplications, and most likely also in other re-
gions of the protein. It is possible, however, that reduction of
the capacity of the primordial b4-GlcNAcT to transfer GalNAc
might have been advantageous for the snail. The increase in
the specificity of the enzyme for UDP-GlcNAc would then have
been of more importance for the snail than the loss of catalytic
potency that coincided with the introduction of the additional
exons.
In b4-GalT the corresponding region (encoded by exon 5) has
been proposed to be involved in UDP-Gal binding (32–34). In
the same region a tetrapeptide (DKKN) has been found that is
conserved between b4-GalT and a3-GalT, which is in support of
this proposition (35). In the human b4-GalT a second region (in
exon 4) has been proposed to be involved in UDP-Gal binding
(36, 37). Interestingly, this latter region shows a high degree of
similarity between the b4-GalTs and the b4-GlcNAcT, whereas
the more downstream region of b4-GalT (encoded by exon 5)
shows much less sequence identity with the corresponding
region in the b4-GlcNAcT (encoded by exons 6, 7, and 8). As the
mammalian b4-GalTs and the L. stagnalis b4-GlcNAcT use
UDP-Gal and UDP-GlcNAc, respectively, it is tempting to as-
sume that the domain that is most conserved between these
enzymes, is involved in the interaction with the UDP part of
the nucleotide-sugar, while the more downstream region is
responsible for the specificity for donor Gal and GlcNAc, re-
spectively. The observation that both native b4-GlcNAcT and
the deletion mutant were inhibited to a similar extent by UDP,
suggesting that the UDP-binding domain is not affected by the
deletion, is in support of this supposition. The lower Km for
UDP-GlcNAc that was found for the mutant enzyme could be
explained by a higher affinity of this enzyme for the GlcNAc
part of the UDP-sugar.
The change in kinetic properties observed with the mutant
enzyme suggests that the region around the insertion in b4-
GlcNAcT is not only involved in interaction with the sugar-
donor, but also in binding of the acceptor substrate. Addition-
ally, in b4-GalT a region (in exon 4) has been identified, that is
involved in interaction of both donor and acceptor substrates
(36, 37). So in both enzymes the donor and acceptor substrate
binding domains seem to be structurally linked. This is con-
ceivable, as both substrates have to be close together for the
transfer reaction. In b4-GalT another binding domain for Glc-
NAc, however, has been localized in exon 2/3 (34). This region
shows a high sequence identity with the corresponding region
in b4-GlcNAcT, which supports the suggestion that this se-
quence is involved in acceptor binding.
We have shown here that the L. stagnalis b4-GlcNAcT can be
transformed to an enzyme that is capable of catalyzing the
transfer of GlcNAc and GalNAc with a similar maximum ve-
locity. This suggests that the b4-GalNAcT, which has been
observed in L. stagnalis tissues (Ref. 9 and this study), might
be encoded by a structurally related enzyme belonging to the
b4-GalT gene family. This is further supported by several stud-
ies that have shown a similarity between invertebrate b4-
GalNAcTs and the mammalian b4-GalTs in acceptor specificity
(9–12), and sometimes in responsiveness to a-lactalbumin (13).
Furthermore, b4-GalT shows sugar donor promiscuity at high
concentrations of UDP-GalNAc (38), or in the presence of a-lac-
talbumin (24), resulting in the transfer of GalNAc. Interest-
ingly, b4-GlcNAcT is not sensitive to a-lactalbumin (4), and
this enzyme can not utilize UDP-Gal, but shows a relatively
high b4-GalNAcT activity (7%). By mutagenesis, we have con-
structed an enzyme with an even higher GalNAcT activity. A
similar experiment has been documented for the blood group A
(a3-GalNAcT) and B (a3-GalT) enzymes (39). These enzymes
also show some nucleotide sugar donor promiscuity (40), but by
construction of hybrids an enzyme with both activities was
obtained (41). Our observations suggest that, in addition to the
facilitation of the transfer of the desired sugar, the prevention
of sugar donor promiscuity might have been a driving force in
the evolution of enzymes of the b4-GalT gene family.
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